Clinical trial
Anti-Thymocyte Globulin, Cyclosporine, and RAD in Islet Transplantation
NCT00286624
Study timeline
Study start (unknown)2003-03-01Date precision: month
Registry last updated2008-05-08
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Type 1 Diabetes Mellitusunresolved
Hypoglycemiaunresolved
Interventions
Allogeneic Islets of LangerhansBIOLOGICAL
EverolimusDRUG · verified · RxNorm: everolimus
CyclosporineDRUG · verified · RxNorm: cyclosporine
Sponsors & collaborators
University of Minnesotalead sponsor
Juvenile Diabetes Research Foundationcollaborator
National Institutes of Health (NIH)collaborator
Novartiscollaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT00286624 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.